01 Jan 2019
Little Green Pharma is pleased to announce the company has been granted an Export Licence by the Federal Department of Health, effective 15 January 2019. Obtaining this license meets one of Little Green Pharma’s key strategic milestones on the path to become a key domestic and international supplier of medical cannabis products.
Managing Director, Fleta Solomon believes the strict growing and manufacturing conditions applicable to local suppliers will ultimately give Australian medical cannabis the edge over international competitors, many of which are subject to less stringent quality and manufacturing standards.
Little Green Pharma’s goal is to make clean and natural, Australian-grown and medical grade medical cannabis products to supply both the Australian and overseas markets in 2019.
Company news
Little Green Pharma have sponsored a new digital platform, GreenChoices to provide both medical practitioners and patients with meaningful research and education, with the aim of assisting them make informed choices about medical cannabis as a possible treatment option.
Aug 2018
Insights
Australia's latest listed medicinal cannabis company has launched onto the market with a bang, scoring a major UK distribution deal the night before landing.
Feb 2020
Insights
Little Green Pharma raised the maximum subscription amount of $10 million in an oversubscribed IPO.
Feb 2020